AAAAAA
Results:
1-7
|
Results: 7
Authors:
Chaudhry, V
Cornblath, DR
Griffin, JW
O'Brien, R
Drachman, DB
Citation: V. Chaudhry et al., Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases, NEUROLOGY, 56(1), 2001, pp. 94-96
Authors:
Wu, B
Wu, JM
Miagkov, A
Adams, RN
Levitsky, HI
Drachman, DB
Citation: B. Wu et al., Specific immunotherapy by genetically engineered APCs: The "guided missile" strategy, J IMMUNOL, 166(7), 2001, pp. 4773-4779
Authors:
Wu, JM
Wu, B
Miagkov, A
Adams, RN
Drachman, DB
Citation: Jm. Wu et al., Specific immunotherapy of experimental myasthenia gravis in vitro: The "guided missile" strategy, CELL IMMUN, 208(2), 2001, pp. 137-147
Authors:
Drachman, DB
Rothstein, JD
Citation: Db. Drachman et Jd. Rothstein, Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis, ANN NEUROL, 48(5), 2000, pp. 792-795
Authors:
Wu, JM
Wu, B
Guarnieri, F
August, JT
Drachman, DB
Citation: Jm. Wu et al., Targeting antigen-specific T cells by genetically engineered antigen presenting cells - A strategy for specific immunotherapy of autoimmune disease, J NEUROIMM, 106(1-2), 2000, pp. 145-153
Authors:
Drachman, DB
Citation: Db. Drachman, Targeting T cells in myasthenia gravis, ANN NEUROL, 46(4), 1999, pp. 553-555
Authors:
McIntosh, KR
Drachman, DB
Citation: Kr. Mcintosh et Db. Drachman, Induction of apoptosis in activated T cell blasts by suppressive macrophages: A possible immunotherapeutic approach for treatment of autoimmune disease, CELL IMMUN, 193(1), 1999, pp. 24-35
Risultati:
1-7
|